XML 21 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
American Biogenetic Sciences, Inc. - Statements of Operations (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Statements of Operations    
Revenue $ 0us-gaap_Revenues $ 0us-gaap_Revenues
General and administrative 28,925us-gaap_GeneralAndAdministrativeExpense 60,750us-gaap_GeneralAndAdministrativeExpense
Interest expenses 11,550us-gaap_InterestExpense 9,120us-gaap_InterestExpense
Total costs and expenses 40,475us-gaap_CostsAndExpenses 69,870us-gaap_CostsAndExpenses
Net income (loss) $ (40,475)us-gaap_NetIncomeLoss $ (69,870)us-gaap_NetIncomeLoss
Basic and diluted net loss $ (0.04)us-gaap_EarningsPerShareBasicAndDiluted $ (0.06)us-gaap_EarningsPerShareBasicAndDiluted
Basic and diluted 1,088,740us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 1,088,740us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted